D

DGX

DGX

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
DGX Live QuoteReal-time
$259.69
+$22.57(+9.52%)1M
Day Range$253.15 – $261.46
Open$254.38
Previous Close$256.35
Volume1.30M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$28.57B
P/E Ratio (TTM)25.9
Forward P/E21.3
EPS (TTM)$10.04
Price to Book3.7
Dividend Yield1.32%
Beta (Volatility)0.55
IndustryDIAGNOSTICS & RESEARCH
52-Week RangeCurrent: $259.69 (96%)
Low: $168.34High: $263.19
Wall Street Consensus
Strong Buy
Analyst Rating
4.8/ 5.0
Target Price
$257.27+71.5% upside

Insider Buys

0

$0

Insider Sales

48

$76.90M

Total Volume

$76.90M

83 transactions

Net Activity

$76.90M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
D
1

Davis J. E.

CEO, Pres

0 buys5 sells

$23.69M total

D
2

Doherty Catherine T.

EVP

0 buys10 sells

$19.29M total

P
3

Prevoznik Michael E

SVP, GC

0 buys11 sells

$18.84M total

K
4

Kuppusamy Karthik

SVP, Clinical Solutions

0 buys5 sells

$4.64M total

P
5

Plewman Patrick

SVP for Diagnostic Services

0 buys9 sells

$4.60M total

Trading History
DGX insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 3, 2026

2 weeks ago

Doherty Catherine T.

EVP

EVP
Sell22.1K$248.02$5.48M

Sep 1, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell122.4K$-10000.00$0

Sep 1, 2026

2 months ago

Davis J. E.

CEO, Pres

CEO
Sell10.0K$242.72$2.43M

Aug 28, 2026

2 months ago

Prevoznik Michael E

SVP, GC

SVP
Sell22.7K$243.11$5.51M

Aug 28, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell42.3K$-22677.00$0

Jul 28, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell10.3K$-1600.00$0

Jul 28, 2026

3 months ago

Delaney Mark E

SVP, Chief Commercial Officer

SVP
Sell1.6K$235.18$376K

Jun 4, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell15.6K$-8147.00$0

Jun 4, 2026

5 months ago

Kuppusamy Karthik

SVP, Clinical Solutions

SVP
Sell8.1K$200.00$1.63M

Jun 1, 2026

5 months ago

Davis J. E.

CEO, Pres

CEO
Sell10.0K$194.14$1.94M

Jun 1, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell132.4K$-10000.00$0

Mar 5, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell71.6K$-5558.00$0

Mar 4, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell15.5K$-2628.00$0

Mar 4, 2026

8 months ago

Kuppusamy Karthik

SVP, Clinical Solutions

SVP
Sell2.6K$204.86$538K

Mar 5, 2026

8 months ago

Plewman Patrick

SVP for Diagnostic Services

SVP
Sell2.9K$206.21$589K

Mar 5, 2026

8 months ago

Prevoznik Michael E

SVP, GC

SVP
Sell3.9K$206.21$800K

Mar 5, 2026

8 months ago

Doherty Catherine T.

EVP, Regional Businesses

EVP
Sell5.6K$206.21$1.15M

Mar 2, 2026

8 months ago

Davis J. E.

CEO, Pres

CEO
Sell10.0K$212.52$2.13M

Mar 3, 2026

8 months ago

Doherty Catherine T.

EVP, Regional Businesses

EVP
Sell632$207.73$131K

Mar 2, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell117.2K$-10000.00$0

Mar 3, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell71.6K$-632.00$0

Mar 3, 2026

8 months ago

Plewman Patrick

SVP for Diagnostic Services

SVP
Sell410$207.73$85K

Mar 3, 2026

8 months ago

Prevoznik Michael E

SVP, GC

SVP
Sell526$207.73$109K

Feb 19, 2026

9 months ago

Doherty Catherine T.

EVP, Regional Businesses

EVP
Sell1.4K$204.83$294K

Feb 19, 2026

9 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell15.8K$-958.00$0

Feb 19, 2026

9 months ago

Prevoznik Michael E

SVP, GC

SVP
Sell1.1K$204.83$228K

Feb 19, 2026

9 months ago

Plewman Patrick

SVP for Diagnostic Services

SVP
Sell958$204.83$196K

Feb 13, 2026

9 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell72.6K$-26165.00$0

Feb 13, 2026

9 months ago

Doherty Catherine T.

EVP, Regional Businesses

EVP
Sell26.2K$206.15$5.39M

Feb 10, 2026

9 months ago

Plewman Patrick

SVP for Diagnostic Services

SVP
Sell5.7K$204.00$1.16M

Feb 10, 2026

9 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell15.4K$-5662.00$0

Nov 25, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell120.5K$-55093.00$0

Nov 25, 2025

11 months ago

Gregg Vicky B

Dir

Director
Sell1.3K$191.76$240K

Nov 25, 2025

11 months ago

Davis J. E.

CEO, Pres

CEO
Sell55.1K$192.22$10.59M

Nov 18, 2025

12 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell7.5K$-7946.00$0

Nov 18, 2025

12 months ago

Delaney Mark E

SVP, Chief Commercial Officer

SVP
Sell7.9K$187.35$1.49M

Oct 22, 2025

13 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell29.4K$-1482.00$0

Oct 22, 2025

13 months ago

Pfeiffer Gary M

Dir

Director
Sell1.5K$182.40$270K

Sep 26, 2025

13 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell43.8K$-227.00$0

Sep 26, 2025

13 months ago

Prevoznik Michael E

SVP, GC

SVP
Sell227$188.13$43K

Sep 23, 2025

14 months ago

Prevoznik Michael E

SVP, GC

SVP
Sell28.5K$187.12$5.33M

Sep 23, 2025

14 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell43.8K$-28463.00$0

Aug 21, 2025

15 months ago

Plewman Patrick

SVP for Diagnostic Services

SVP
Sell2.0K$185.00$365K

Aug 21, 2025

15 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell15.3K$-1975.00$0

Aug 19, 2025

15 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell17.2K$-4532.00$0

Aug 19, 2025

15 months ago

Plewman Patrick

SVP for Diagnostic Services

SVP
Sell4.5K$183.00$829K

Aug 15, 2025

15 months ago

Plewman Patrick

SVP for Diagnostic Services

SVP
Sell2.0K$180.00$356K

Aug 15, 2025

15 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell17.2K$-1975.00$0

Aug 6, 2025

15 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell19.2K$-5535.00$0

Aug 6, 2025

15 months ago

Plewman Patrick

SVP for Diagnostic Services

SVP
Sell5.5K$175.00$969K

Jul 30, 2025

15 months ago

Kuppusamy Karthik

SVP, Clinical Solutions

SVP
Sell10.5K$167.95$1.76M

Jul 30, 2025

15 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell10.4K$-10479.00$0

May 12, 2025

18 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell7.5K$-1748.00$0

May 12, 2025

18 months ago

Delaney Mark E

SVP, Chief Commercial Officer

SVP
Sell1.7K$175.52$307K

Apr 2, 2025

19 months ago

Davis J. E.

CEO, Pres

CEO
Sell39.2K$168.46$6.60M

Apr 2, 2025

19 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell127.6K$-39191.00$0

Apr 2, 2025

19 months ago

Kuppusamy Karthik

SVP, Clinical Solutions

SVP
Sell2.6K$170.00$434K

Mar 17, 2025

20 months ago

Prevoznik Michael E

SVP, GC

SVP
Sell4.6K$170.00$789K

Mar 17, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell43.8K$-4643.00$0

Mar 5, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell72.5K$-5370.00$0

Mar 5, 2025

20 months ago

Doherty Catherine T.

EVP, Regional Businesses

EVP
Sell5.4K$174.13$935K

Mar 4, 2025

20 months ago

Doherty Catherine T.

EVP, Regional Businesses

EVP
Sell716$175.79$126K

Mar 4, 2025

20 months ago

Prevoznik Michael E

SVP, GC

SVP
Sell592$175.79$104K

Mar 4, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell77.9K$-716.00$0

Feb 27, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell44.7K$-528.00$0

Feb 27, 2025

21 months ago

Prevoznik Michael E

SVP, GC

SVP
Sell528$172.61$91K

Feb 27, 2025

21 months ago

Doherty Catherine T.

EVP, Regional Businesses

EVP
Sell824$172.61$142K

Feb 19, 2025

21 months ago

Plewman Patrick

SVP for Diagnostic Services

SVP
Sell320$169.71$54K

Feb 20, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell45.5K$-604.00$0

Feb 20, 2025

21 months ago

Prevoznik Michael E

SVP, GC

SVP
Sell604$170.99$103K

Feb 19, 2025

21 months ago

Doherty Catherine T.

EVP, Regional Businesses

EVP
Sell1.4K$170.51$245K

Feb 19, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell18.1K$-320.00$0

Feb 5, 2025

21 months ago

Gregg Vicky B

Dir

Director
Sell1.3K$164.57$206K

Feb 5, 2025

21 months ago

Delaney Mark E

SVP, Chief Commercial Officer

SVP
Sell403$164.30$66K

Feb 5, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell16.9K$-1250.00$0

Nov 29, 2024

24 months ago

Prevoznik Michael E

SVP, GC

SVP
Sell35.1K$163.07$5.73M

Nov 27, 2024

24 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell72.8K$-33103.00$0

Nov 29, 2024

24 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell44.1K$-35146.00$0

Nov 27, 2024

24 months ago

Doherty Catherine T.

EVP, Regional Businesses

EVP
Sell33.1K$162.99$5.40M

Nov 6, 2024

24 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell35.6K$-18755.00$0

Nov 6, 2024

24 months ago

Deppe Michael J

SVP, Corp. Controller, CAO

SVP
Sell18.8K$154.05$2.89M

Oct 28, 2024

25 months ago

Kuppusamy Karthik

SVP, Clinical Solutions

SVP
Sell1.8K$156.92$279K

Oct 28, 2024

25 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell11.7K$-1775.00$0
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
DGX Buy Conviction0%
Industry Rank#188 of 563
Volume Contribution0.5%
Total Industry Activity$16.73B

DGX has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. DGX ranks #188 in insider activity out of 563 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for DGX

Over the last 90 days, corporate insiders at DGX (DGX) engaged in a total of 83 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 48 were sales. The total volume of insider trading reached $76.90M.

The net insider activity for DGX shows a net selling bias of $76.90M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Davis J. E. (CEO, Pres), who traded 55.1K shares valued at $10.59M on Nov 25, 2025.

Live Market News & Developments
Aggregated real-time headlines for DGX (DGX)
6 updates

Quest Diagnostics Incorporated (DGX) Stock Price, News, Quote & History

Yahoo! Finance Canada5h ago

Quest Diagnostics Incorporated (DGX) stock price, news, quote and history

Yahoo Finance UKYesterday

Quest Diagnostics (NYSE:DGX) Share Price, Forecast & Analysis

Stocks Down UnderYesterday

Is This the Right Time to Add DGX Stock to Your Portfolio?

Zacks Investment Research58d ago

Is This the Right Time to Hold DGX Stock in Your Portfolio?

Zacks Investment Research184d ago

Quest Diagnostics Incorporated (DGX) Stock Forecasts

Yahoo Finance6h ago

FAQs About DGX Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for DGX.

Based on SEC Form 4 disclosures, the Insider Confidence Score for DGX is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 48 sales by company executives over the last 90 days.

The CEO Conviction Index for DGX is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.